Wintermar Offshore (WINS:JK) Public Expose 2023

JAKARTA, Jun 16, 2023 – (ACN Newswire) – PT Wintermar Offshore Marine Tbk (WINS:JK) invested US$3.15 million out of capex plan of US$18 million in 2023, and expects higher demand for OSVs driven by a jump in approved deepwater oil and gas investments and tight OSV supply. During the Public Expose on 16 June 2023, PT Wintermar Offshore Marine Tbk unveiled its strategic plans to enhance fleet composition and profitability, positioning itself to capitalize on the anticipated upturn in the oil and gas industry.

The Company expressed a bullish outlook on O&G as a jump in approved investments in deepwater projects is expected to raise the demand for high-value Offshore Supply Vessels (OSVs) in the coming years. Wintermar aims to ride on the upturn, having added high tier fleet capacity, and stands to benefit from rising charter rates.

In 2021, the Company successfully acquired 2 vessels, followed by an additional 6 vessels in 2022, and acquired 1 more vessel in 2023. Out of the total of 9 vessels, 5 are currently operational. Meanwhile, out of the remaining 4 vessels, it is expected that 2 vessels will start operating in June 2023, 1 vessel to be ready to work in July, leaving only 1 vessel still in the process of reactivation.

Fleet utilization in the first quarter of 2023 was 67%, an increase from 61% in the first quarter of 2022, but still lower compared to the high utilization rate of 82% in the fourth quarter of 2022. The decrease in utilization is due to several vessels undergoing a transition after the completion of contracts. Some vessels were undergoing maintenance for preparation of long term contract engagements.

Management revealed that average vessel charter rates so far in 2023 are 35% higher than the average rental rates in 2022 for high tier vessels and 8% for mid tier vessels.

With the improvement in the oil and gas and OSV sector, the Company is expecting an increase in charter rates and utilization in the second half of 2023. This reflects the success in securing several longer-term contracts that will commence in the third and fourth quarters of 2023.

Finance Director Janto Lili reported that the Company succeeded in maintaining strong financial performance and solid debt management. The Company's Gross Profit for 1Q2023 reached US$1.6 million, reflecting a significant improvement compared to the previous year. With a low net gearing of 10.0%, Wintermar is well-positioned to fund its growth initiatives and market opportunities.

Managing Director of Wintermar, Sugiman Layanto expressed confidence in the coming years, as Wintermar anticipates a strong increase in demand for offshore support vessels driven by increasing investment in new projects in the deepwater oil and gas sector. This positive outlook comes at a time when the supply for OSVs remains tight due to the industry downturn over the past years.

For the future, Wintermar will continue to focus on selective acquisition of higher value vessels to improve the profitability of the overall fleet.

As at end of April 2023, the Company's Contracts on hand amounted to US$66 million.

About Wintermar Offshore Marine Group

Wintermar Offshore Marine Group (WINS.JK), developed over nearly 50 years with a track record of quality that is both a source of pride and responsibility that we are dedicated to upholding, and sails a fleet of more than 48 Offshore Support Vessels ready for long term as well as spot charters. All vessels are operated by experienced Indonesian crew, tracked by satellite systems and monitored in real-time by shore-based Vessel Teams.

Wintermar is the first shipping company in Indonesia to be certified with an Integrated Management System by Lloyd's Register Quality Assurance, and is currently certified with ISO 9001:2015 (Quality), ISO14001:2015 (Environment) and OHSAS 18001:2007 (Occupational Health and Safety). For more information, please visit www.wintermar.com.

For further information, please contact:
Ms. Pek Swan Layanto, CFA
Investor Relations
PT Wintermar Offshore Marine Tbk
Tel (62-21) 530 5201 Ext 401
Email: investor_relations@wintermar.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Sri Trang Agro-Industry (SET:STA) Expands Business in Ivory Coast

BANGKOK, Jun 16, 2023 – (ACN Newswire) – Sri Trang Agro-Industry PCL (SET: STA), the world's leading fully integrated green rubber company and Thailand's largest producer of rubber gloves, has opened the Company's first raw material procurement center in Ivory Coast, aiming to expand its sources of raw material as well as providing agricultural knowledge to local rubber plantation farmers. The plan is to establish a total of five procurement centers in the country within next year. Ivory Coast is projected to have a production capacity of over 1.3 million metric tons of rubber this year, surpassing Vietnam and becoming the world's 3rd largest rubber exporter.

Sri Trang Agro-Industry PCL runs the business with expertise and sustainability from upstream to downstream. The World‘s Leading Fully Integrated Green Rubber Company specializing in rubber plantation management and natural rubber products, it is the only Thai rubber company dually listed on the Stock Exchange of Thailand (SET: STA) and the Singapore Exchange (SGX: NC2).

Mr. Veerasith Sinchareonkul, Managing Director and Executive Director of Sri Trang Agro-Industry PCL revealed that it had established a subsidiary last year in Ivory Coast, or Cote d'Ivoire, to support business expansion through procurement of raw materials from new sources, most recently on June 1. The Company commissioned the first center to assess raw material sources with high growth potential, while planning to open five procurement centers by 2024, expanding its capability and coverage in sourcing raw materials.

The primary driver behind the subsidiary and procurement centers in Ivory Coast is the suitable climate and environment or cultivating rubber trees, resulting in continuous increases in production. Therefore, the country holds significant potential for rubber production and export. The International Rubber Study Group (IRSG) estimated that by 2023 Ivory Coast is projected to have a total rubber production capacity of 1.31 million tons, an increase of 23 percent from 2021, with projections of 1.37 million metric tons and 1.42 million metric tons in 2024 and 2025, respectively.

At present, Ivory Coast is the world's 4th largest exporter of rubber, following Thailand, Indonesia, and Vietnam. However, IRSG forecasts that Ivory Coast's rubber production will surpass Vietnam's and become the world's 3rd largest rubber exporter within this year.

"We recognize that accessing new supplies in Ivory Coast will greatly support the Company's business in terms of expanding the sources of raw materials. In addition, our on-ground team is also providing agricultural knowledge on rubber cultivation to rubber plantation farmers in Ivory Coast, further enhancing the country's capability as one of the world's top producers of high-quality raw materials," Mr. Veerasith added.

Released by Public Relations Dept., MT Multimedia Co., Ltd. for Sri Trang Agro-Industry PCL
For additional information, please contact: Wasana "Jeab" Wongsiri
Tel: +66 84 359 0659, +66 2 612 2081 ext.131; E: wasana.w@mtmultimedia.com

Sri Trang Agro-Industry PCL, www.sritranggroup.com/en/home
[SET: STA] [SGX: NC2] [FRA: YTAA] [OTCPK: SLJUY]

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Asia’s Banking, Payments, E-Commerce and Retail Leaders to Gather in Singapore this Month for the First Time in More Than Four Years at Seamless Asia

Seamless Asia, the leading annual gathering of Asia’s commerce leaders, will take place in Singapore at Marina Bay Sands Expo and Convention Centre on 27 – 28 June 2023. After a series of annual virtual editions, the event marks the first in-person edition of the event since 2019.

Over 2,500 of the region’s leading banks, payments players, digital wallets, e-commerce retailers, telcos, government bodies will attend Seamless Asia 2023 to reconnect, explore and shape the future of digital commerce in Asia. From structured round-table sessions to informal networking gatherings, there will be ample opportunities for attendees to build relationships and forge meaningful partnerships.

“With digital payments in Asia forecast to exceed $350 billion USD by 2026 and with e-commerce spending in Southeast Asia expected to reach $180 billion USD by 2025 it’s a time of tremendous growth in the region” says Paul Clark, Managing Director – Asia, Terrapinn Pte Ltd. “Over recent years, the payments, banking and e-commerce sectors have been at the forefront of innovation. Now is the perfect time to bring together the region’s digital commerce leaders to explore how to truly capitalise on this growth, how to ride the waves of market volatility and to explore what we can expect next in the world’s fastest growing commerce market.”

More than 200 thought leaders will share insights across seven key content pillars: Payments Innovation, Payments Security, eKYC & Authentication, Banking Transformation, E-commerce Strategy, E-commerce Marketing and Online Payments. The engaging presentations and panel discussions will address pressing trends, challenges and opportunities in digital commerce. Speakers at the event include:

Albert Tinio, Co-Chief Executive Officer and Chief Commercial Officer, GoTyme Bank
Alin Dobrea, Head of Marketing Solutions & Partnerships, Zalora
Carlo Brillantes, Head of Digital Payments, foodpanda
Chandana Sunder, Senior Vice President, LazMall Marketing Solutions, Lazada
Darrick Rochili, Chief Innovation Officer, DANA Indonesia
Dipashree Das, Head of Partner Marketing, APAC & ANZ, Amazon
Henry Aguda, CEO and President, UnionDigital Bank
Hung Nguyen, Head of Regional D2C & Emerging Verticals, TikTok
Ida Mok, Co-Founder and President, Women In Blockchain Asia (WIBA)
Ingrid Rose Ann Beroña, Chief Risk Officer, Gcash
Julie Reyes, Chief Risk and Compliance Officer, Maya
Lito Villanueva, Executive VP & Chief Innovation & Inclusion Officer, RCBC
Lucose Eralil, Executive Vice President and Head of Enterprise Technology and Operations, Security Bank
Lynn Huang, Ex-CMO, Asia Pacific, Honeywell SPS, Motorola Solutions
Sharon Tan, Chief Operating Officer, DBS Bank
SheueChee Beh, Director, Payments APAC, Uber
Smriti Modi, Head of Consumer & eTail Marketing, APAC, Poly (HP)
Sonal Kapoor, Senior Director, Flipkart
Tiffany Chng, Co-Founder & Marketing Director, cheak
Will Vayakornvichit, Chief Financial Officer, Love, Bonito

Over 170 sponsors, exhibitors and partners will showcase their cutting-edge products, services, and solutions, including Platinum Sponsors 8×8, Alipay+, CleverTap, HPS, Stripe and World First Asia Pte Ltd. On the exhibition floor, attendees will have the chance to demo solutions and interact directly with product experts to discover innovations that will propel their businesses forward and identify new partnership opportunities.

Seamless Asia 2023 will help accelerate the transformation of digital commerce in Asia. For event information and full conference agenda, visit www.terrapinn.com/SeamlessAsia.

About Seamless Asia 2023

Seamless Asia 2023 will take place at Marina Bay Sands Expo and & Convention Centre, Singapore on 27 – 28 June 2023.

About Terrapinn

Terrapinn has been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together, discussing and demonstrating the technology, strategies and personalities that are changing the way the world does business. Whether you’re looking to make new connections, introduce product or inspire change in your industry, we invite you to join us as agitators of change. Terrapinn – spark something.

Press attendance is complimentary. Enquiries should be directed to:
Jia Le Lim
Marketing Manager
Terrapinn Asia
jiale.lim@terrapinn.com

JBM Healthcare Announces FY2023 Annual Results

HONG KONG, Jun 15, 2023 – (ACN Newswire) – JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period").

KEY HIGHLIGHTS
— Year-on-year revenue up by 28.1% totalled HK$520.3 million
— Profit attributable to equity shareholders increased by 132%, amounting to HK$57.1 million
— Proprietary Chinese medicines business witnessed robust growth of 54.5%
— The Board recommends a final dividend of HK2.5 cents per share
— Cross-border e-commerce business gained tremendous traction alongside expanded product offerings and growing customer traffic
— Rosy growth prospect of the proprietary Chinese medicine business substantiated by increasing consumer acceptance and a broadened geographic reach

Amidst the steady recovery in Hong Kong's economy fueled by the gradual easing of COVID-19 restrictions, the Group witnessed a notable rise in overall sales, propelled by improving consumer sentiment. During the Reporting Period, the Group's total revenue was HK$520.3 million, reflecting a remarkable growth of 28.1%, driven primarily by the strong performance of proprietary Chinese medicines.

The Group's gross profit amounted to HK$205.5 million, an increase of 27.2%, while the consolidated profit attributable to equity shareholders amounted to HK$57.1 million, a significant increase of 132%. Such an increase was mainly attributable to the uplifted revenue of the Group's cross-border e-commerce business, alongside the strong performance of the proprietary Chinese medicine business.

The Board recommends a final dividend of HK2.5 cents per share. Including the interim dividend of HK0.5 cent per share already paid, the total dividend for FY2023 would be HK3.0 cents per share.

Market-Driven Portfolio Bolstered Resilient Performance

Despite the market challenges posed by COVID-19, JBM Healthcare's portfolio demonstrated resilience during the Reporting Period. Carrying a range of well-known brands spanning branded medicines, proprietary Chinese medicines and health supplements, the Group delivered consistent revenue growth, driven primarily by strong performance in proprietary Chinese medicines coupled with a promising cross-border e-commerce sales trend.

On the proprietary Chinese medicines business, sales revenue surged by 54.5% to HK$359.8 million, as the stabilisation of the pandemic led to a gradual recovery in retail sentiment and increased demand for Chinese medicine services. This growth was driven by the strong momentum of the Concentrated Chinese Medicine Granules ("CCMG") business, as well as the significant increase in sales of Po Chai Pills.

Cross-Border E-commerce Development Gained Traction

The Group's cross-border e-commerce business in the PRC has gained strong momentum, experiencing significant growth compared to the previous period.

The Group's two self-operated flagship stores on Tmall Global Marketplace and JD Worldwide made significant strides in expanding the market share and customer base during the Reporting Period. With the strong performance of the Group's leading brand product, Ho Chai Kung Tji Thung San, our flagship store achieved a top ranking on Tmall and secured the No.1 position in the "OTC-International" and "OTC-Pain Killer" categories during the Double 12 Event. Other popular brand products like Po Chai Pills also demonstrated promising growth in the Reporting Period.

The Group has also expanded its domestic e-platform, Go-Smart, allowing prospective customers in the PRC to gain access to making purchases on JBM Healthcare's health supplement products.

Capturing Growth Potential in Chinese Medicines

To facilitate the entry of Hong Kong traditional propriety Chinese medicines into the Greater Bay Area, the government of Guangdong Province has introduced streamlined measures to enable eligible proprietary Chinese medicines for external use to apply for registration with the Guangdong Provincial Medical Products Administration (GDMPA). Leveraging this favorable policy, the Group has successfully obtained registration approval for its medicated oil brands, Shiling Oil and Konsodona Medicated Oil, in the Greater Bay Area, anticipating the launch of the products in the market in the near term.

Acquisition to Enhance Portfolio and Platform

The Group recently completed the acquisition of a joint venture company specialising in developing and marketing health and wellness product brands. The joint venture company has established a robust distribution network for proprietary medicines and health and wellness products, including the development of supplement brands "SEASONS" and "Slimming Expert". With this acquisition, the Group aims to enhance its health and wellness portfolio and distribution platform, capitalising on the rising consumer healthcare market in the Greater Bay Area.

Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare, said, "In FY2023, JBM Healthcare demonstrated resilience despite challenges from the fifth wave of the epidemic and external market pressures. Our strengths lie in our robust portfolio of well-known brands, alongside strong commercial execution and adaptability to market changes.

We are optimistic about the healthcare sector's future outlook. Our focus is on promoting operational excellence as we pursue growth strategies. These include expanding our e-commerce platforms, leveraging the potential of proprietary Chinese medicines in the Greater Bay Area, aligning our product portfolio with a strong commercial execution. By doing so, we aim to provide consumers with high-quality branded healthcare products that help them manage their health effectively, advancing our mission of Enabling Better Health Through Self-Care."

About JBM (Healthcare) Limited (Stock Code: 2161)
JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries. The Group is a unique sector player with marketing expertise and a drug heritage that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex, BITE-X, Mederma for Kids, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk

For media inquiries, please contact:
Strategic Financial Relations Limited
Vicky Lee Tel: (852) 2864 4834 Email: vicky.lee@sprg.com.hk
Rachel Ko Tel: (852) 2114 2370 Email: rachel.ko@sprg.com.hk
Katrina Hui Tel: (852) 2114 4318 Email: katrina.hui@sprg.com.hk
Fax: (852) 2527 1196

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Thriver Launches Groundbreaking AI Chatbot to Enhance Workplace Service Management

Thriver, a leading technology company specializing in workplace service management, is proud to announce the release of its revolutionary AI Chatbot. This cutting-edge addition to the Thriver platform further enhances the user experience and simplifies the management of workplace services.

TORONTO, ON / ACNNEWSWIRE / June 15, 2023 / The Thriver AI Chatbot, developed by Thriver’s R&D team, leverages the power of artificial intelligence to provide users with seamless access to recommendations, bookings, and support within the Thriver technology suite. This intelligent culture concierge empowers employees to effortlessly request and receive personalized recommendations for a wide range of workplace services based on their unique preferences and needs.

Thriver AI Chatbot
The Thriver AI Chatbot can browse the marketplace, make recommendations, gather feedback and much more.

“We are excited to introduce the Thriver AI Chatbot as a game-changing feature for our platform,” said Eran Henig, CEO & CTO of Thriver. “Being the first player in our industry to launch such an innovative solution, our goal is to continuously evolve and provide our clients with the most advanced tools to streamline their workplace service management. The AI Chatbot brings a new level of convenience and personalization to our users, empowering them to create exceptional employee experiences.”

The AI Chatbot not only facilitates service discovery and bookings but also provides real-time support and assistance. It automates routine tasks, answers frequently asked questions, and collects valuable feedback from users to continuously improve the platform and enhance the overall employee experience.

One of the key advantages of the Thriver AI Chatbot is its integration with the existing Thriver ecosystem. It seamlessly connects with other features of the platform, such as Thriver‘s proprietary marketplace with thousands of workplace culture services. The AI Chatbot is also integrated with Thriver‘s group ordering and employee feedback tools to create a comprehensive and cohesive solution for workplace service management.

“We have been using Thriver‘s platform to manage our workplace services, and the addition of the AI Chatbot has been truly transformative,” said Mike Davis, CEO at Cloud Core Group. “The convenience and personalized recommendations provided by the Chatbot have greatly enhanced our employee experience, saving us valuable time. Thriver continues to exceed our expectations with their commitment to cutting-edge solutions and exceptional service.”

Thriver remains committed to leveraging innovative technologies to transform the way businesses manage their workplace services. The introduction of the AI Chatbot reinforces Thriver‘s position as a market leader and underscores its dedication to providing clients with state-of-the-art tools and exceptional user experiences.

To learn more about Thriver and sign up for early access, visit the Thriver for Business page.

Contact Information

Valeria Latman
VP Marketing
valeria@thriver.com
1-855-765-4355

SOURCE: Thriver

View source version on accesswire.com:
https://www.accesswire.com/761353/Thriver-Launches-Groundbreaking-AI-Chatbot-to-Enhance-Workplace-Service-Management

Kontent.ai Introduces Industry’s First CMS With Native AI Capabilities

Transforming the Content Management Process Across Organizations – Faster, Better, and Smarter

NEW YORK, NY / ACNNEWSWIRE / June 15, 2023 / Industry-leading headless CMS Kontent.ai today announced native AI capabilities that will further transform the ability to have complete control to create and manage content across an organization. Building native AI-powered skills into Kontent.ai is an evolution of the solution, designed to meet evolving customer and market needs.

Kontent.ai’s AI native capabilities

Unlike other solutions, Kontent.ai delivers the first and only context-aware AI that is fully integrated into the product. This provides control of content from ideation to editing to customer experience in real-time, showing what content will look like on your own websites and applications. As demands for content across organizations increase, teams struggle to manage, maintain, and govern content at scale. Kontent.ai solves this challenge in a single solution.

“Native AI skills inside Kontent.ai leverage the power of artificial intelligence while minimizing the risks often associated with it,” said Petr Palas, Founder, Kontent.ai. “Content management challenges will only increase as more content is generated with the adoption of AI. However, we anticipated this and built a solution that works across the organization for the marketer, the developer, and the content creator.”

Benefits of native AI skills include:

Increased efficiency – Improve all stages of the content management process from creation to review with the power and speed of AI
Faster time to value – Leverage native AI skills immediately without the need for external integrations, plug-ins, or development resources within a headless CMS
Consistency at scale – Develop core content, versions, style, tone of voice, and more instantly
Simplified content governance – Safeguard brand and content guidelines seamlessly

“The vision and innovation of Kontent.ai is what makes them a trusted partner,” reports Michael D’Orio, VP of Marketing from American Bath Group. “As a long-term customer, who just won the MACH Impact Awards for Best Overall Change Product by the MACH Alliance, we’ve reached new levels of success with Kontent.ai and look forward to the newest solution.”

Learn more about the native AI capabilities of Kontent.ai on the upcoming webinar June 20, 2023. An early access program for current customers is available, join the waitlist here.

Contact Information

Vojtech Boril
Vice President, Growth & Marketing
vojtech.boril@kontent.ai
+420776874572

Erika Goldwater
PR & Communications
erika.goldwater@chameleon.co
+1 6174073578

Thriver Launches Groundbreaking AI Chatbot to Enhance Workplace Service Management

TORONTO, ON, Jun 15, 2023 – (ACN Newswire) – The Thriver AI Chatbot, developed by Thriver's R&D team, leverages the power of artificial intelligence to provide users with seamless access to recommendations, bookings, and support within the Thriver technology suite. This intelligent culture concierge empowers employees to effortlessly request and receive personalized recommendations for a wide range of workplace services based on their unique preferences and needs.

Thriver AI Chatbot
The Thriver AI Chatbot can browse the marketplace, make recommendations, gather feedback and much more.

With the Thriver AI Chatbot, employees can now converse with a virtual culture concierge to easily explore and discover the trendiest and most exciting team services available through the Thriver marketplace. Whether it's booking a team-building activity, ordering food for the office, or planning their holiday party, the AI Chatbot is a one-stop solution for all workplace service needs.

"We are excited to introduce the Thriver AI Chatbot as a game-changing feature for our platform," said Eran Henig, CEO & CTO of Thriver. "Being the first player in our industry to launch such an innovative solution, our goal is to continuously evolve and provide our clients with the most advanced tools to streamline their workplace service management. The AI Chatbot brings a new level of convenience and personalization to our users, empowering them to create exceptional employee experiences."

The AI Chatbot not only facilitates service discovery and bookings but also provides real-time support and assistance. It automates routine tasks, answers frequently asked questions, and collects valuable feedback from users to continuously improve the platform and enhance the overall employee experience.

One of the key advantages of the Thriver AI Chatbot is its integration with the existing Thriver ecosystem. It seamlessly connects with other features of the platform, such as Thriver's proprietary marketplace with thousands of workplace culture services. The AI Chatbot is also integrated with Thriver's group ordering and employee feedback tools to create a comprehensive and cohesive solution for workplace service management.

"We have been using Thriver's platform to manage our workplace services, and the addition of the AI Chatbot has been truly transformative," said Mike Davis, CEO at Cloud Core Group. "The convenience and personalized recommendations provided by the Chatbot have greatly enhanced our employee experience, saving us valuable time. Thriver continues to exceed our expectations with their commitment to cutting-edge solutions and exceptional service."

Thriver remains committed to leveraging innovative technologies to transform the way businesses manage their workplace services. The introduction of the AI Chatbot reinforces Thriver's position as a market leader and underscores its dedication to providing clients with state-of-the-art tools and exceptional user experiences.

To learn more about Thriver and sign up for early access, visit the Thriver for Business page. https://pr.report/lRV6ugef

Contact Information
Valeria Latman
VP Marketing
valeria@thriver.com
1-855-765-4355

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Penta Unveils Brighter Future Award 2023: Recognising Innovators and Visionaries Driving Positive Change

Penta announces the inaugural Brighter Future Award to honour maternal and child health champions

PADOVA, ITALY / ACNNEWSWIRE / June 15, 2023 / Penta, an international independent scientific network dedicated to maternal and child health research, is proud to unveil the Brighter Future Award (BFA), an annual global event designed to celebrate the remarkable efforts of individuals and organisations working tirelessly to improve health outcomes for children and pregnant individuals living with infectious diseases worldwide.

Penta Brighter Future Award
An illustration diverse group of children holding hands with the Fondazione Penta ETS logo

As we acknowledge the vital role of local champions in driving positive change, the BFA aims to recognise these outstanding change-makers and provide opportunities for scientists to connect with and learn from local communities at the forefront of maternal and child health.

“Our children are our future, and their well-being should be a shared responsibility that transcends scientific boundaries. Only by fostering collaboration, advocacy, and policy changes can we ensure that the scientific advancements translate into tangible improvements for every child, paving the way for a healthier, brighter tomorrow,” said Carlo Giaquinto, President of Fondazione Penta ETS and Professor of Paediatrics at the University of Padua, Italy.

Seven winners will be selected by an international jury of experts in their fields. The winners will each receive a €5,000 prize to support their ongoing work. Additionally, the BFA will provide all-expenses-paid trips for the winners to attend the 2024 Penta ID Network meeting in Italy. This prestigious event offers a platform for the winners to share their work with Penta researchers and join a network of like-minded professionals dedicated to child health.

The BFA comprises two categories:

Penta’s Brighter Future Award: Six awards, one for each of the six global regions
Penta’s Brighter Future Young Researcher Award: One award to a young researcher in the maternal and child health fields.

Nominations for the Penta BFA are open from June 15 to September 15, 2023. A distinguished panel of experts, including scientists, child health specialists and experts in youth participation in medical research from across the globe, will evaluate the nominations based on criteria such as innovation, sustainability, community engagement and social justice. Winners will be announced on December 1, 2023.

More about the BFA nomination process in this video: https://youtu.be/6bCvobzbExc

By recognising the outstanding efforts of those working to make a real difference in maternal and child health worldwide, we hope to inspire others to follow in their footsteps and work towards creating positive change in their own communities.

For more information about the Brighter Future Award and Penta, please visit https://penta-id.org/bfa.

Contact Information

Francesca Mazzetto
Penta Senior Communications Manager
francesca.mazzetto@pentafoundation.org
+393486151202

SOURCE: Fondazione Penta ETS

View source version on accesswire.com:
https://www.accesswire.com/761467/Penta-Unveils-Brighter-Future-Award-2023-Recognising-Innovators-and-Visionaries-Driving-Positive-Change

OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position

PHILADELPHIA, PA / ACNNEWSWIRE / June 15, 2023 / OKRA.ai, an Envision Pharma Group (Envision) company, has appointed senior leader Dr. Yahya Anvar as Chief of AI Science & Insights to unleash the full potential of artificial intelligence (AI) and to further support the life sciences industry.

“I am excited about continuing the innovative collaboration between Envision and OKRA.ai along with Yahya as a senior leader as it further solidifies our Envision commitment to the expansion of OKRA.ai and leadership in the AI and technical space,” shares Meg Heim, CEO of Envision Pharma Group. “His leadership is critical to our vision to accelerate the delivery of our compelling combination of technology-enabled capabilities and solutions to clients as we continue to strengthen our offerings across the product life cycle, but more importantly to support patients in their journey to health and wellness.”

Anvar joined OKRA.ai in 2019, heading the Data Science team. During his tenure, he has led the development of AI solutions across OKRA.ai’s portfolio of products and services. Prior to joining the company, he served as the principal investigator of preclinical personalized medicine at Leiden University Medical Center. He has over 14 years of experience in the healthcare sector and is the author of over 30 peer-reviewed scientific articles. Anvar holds a PhD in Computational Biology from the faculty of Medicine at Leiden University, and an MSc in Bioinformatics and Artificial Intelligence from Brunel University.

Anvar shares, “It is an absolute privilege to be leading the AI insights and science at Envision and pushing the boundaries of what AI has to offer to better patients’ outcomes. Making an impact through solutions that provide actionable, explainable insights is what we thrive for. There is no better time for new beginnings than today, and I’m so excited to be working with the Envision team to transform the industry as we know it.”

Dr. Loubna Bouarfa, Head of AI & Innovative Platforms at Envision, shares, “It was a pleasure to work with Yahya; he has been an exceptional leader of the Data Science team at OKRA.ai. His role has now expanded to cover AI insights and scientific expertise across the entire Envision organization following our recent acquisition. I look forward to working with him in driving AI innovation and propelling Envision to new heights.”

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information:

Colleen Carter
Associate Director, Communications, Office of CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856

SOURCE: Envision Pharma Group

View source version on accesswire.com:
https://www.accesswire.com/761331/OKRAai-an-Envision-Pharma-Group-Company-Appoints-Dr-Yahya-Anvar-to-Senior-Leadership-Position

OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position

PHILADELPHIA, PA, Jun 15, 2023 – (ACN Newswire) – OKRA.ai, an Envision Pharma Group (Envision) company, has appointed senior leader Dr. Yahya Anvar as Chief of AI Science & Insights to unleash the full potential of artificial intelligence (AI) and to further support the life sciences industry.

"I am excited about continuing the innovative collaboration between Envision and OKRA.ai along with Yahya as a senior leader as it further solidifies our Envision commitment to the expansion of OKRA.ai and leadership in the AI and technical space," shares Meg Heim, CEO of Envision Pharma Group. "His leadership is critical to our vision to accelerate the delivery of our compelling combination of technology-enabled capabilities and solutions to clients as we continue to strengthen our offerings across the product life cycle, but more importantly to support patients in their journey to health and wellness."

Anvar joined OKRA.ai in 2019, heading the Data Science team. During his tenure, he has led the development of AI solutions across OKRA.ai's portfolio of products and services. Prior to joining the company, he served as the principal investigator of preclinical personalized medicine at Leiden University Medical Center. He has over 14 years of experience in the healthcare sector and is the author of over 30 peer-reviewed scientific articles. Anvar holds a PhD in Computational Biology from the faculty of Medicine at Leiden University, and an MSc in Bioinformatics and Artificial Intelligence from Brunel University.

Anvar shares, "It is an absolute privilege to be leading the AI insights and science at Envision and pushing the boundaries of what AI has to offer to better patients' outcomes. Making an impact through solutions that provide actionable, explainable insights is what we thrive for. There is no better time for new beginnings than today, and I'm so excited to be working with the Envision team to transform the industry as we know it."

Dr. Loubna Bouarfa, Head of AI & Innovative Platforms at Envision, shares, "It was a pleasure to work with Yahya; he has been an exceptional leader of the Data Science team at OKRA.ai. His role has now expanded to cover AI insights and scientific expertise across the entire Envision organization following our recent acquisition. I look forward to working with him in driving AI innovation and propelling Envision to new heights."

About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 18 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.

Contact Information:
Colleen Carter
Associate Director, Communications, Office of CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com